11 of 50
Home
Bayer Group
Chairman’s Letter
Corporate Structure
Credo
Science For A Better Life
Board of Management
Report of the Supervisory Board
Corporate Governance
Global commitment to sustainability
Governance Bodies
Organization Chart
Financial Report
Bayer Group Key Data
Five-Year Financial Summary
Management Report
Overview of Sales, Earnings and Financial Position
Operating Environment in 2007
Performance by Subgroup and Segment
Calculation of EBIT(DA) Before Special Items
Value Management
Liquidity and Capital Resources
Earnings Performance
Asset and Capital Structure
Information Required Under Takeover Law
Proposal for Distribution of the Profit
Employees
Procurement and Distribution
Research and Development
Sustainable Development
Corporate Social Responsibility
Compensation Report
Risk Report
Subsequent Events
Future Perspectives
Financial Statements
Stock
Focus
News
A century of culture at Bayer
Rivaroxaban submitted for approval
Group plans to expand polyurethane capacities
Former Bayer CFO Helmut Loehr dies
New crop protection active ingredients approved
Werner Wenning named “2007 Manager of the Year”
2008 Otto Bayer Prize goes to DNA scientist
Nexavar® approved in the U.S. to treat liver cancer
Bayer tower to be converted into a media facade
Tunza youth environmental conference focuses on international climate debate
Services
Services Overview
Download Center
Index from A to Z
Glossary
Statements of Income
Balance Sheets
Statements of Cash Flows
Statements of Recognized Income and Expense
Notes
Key Data by Segment and Region
General Information
Effects of new accounting pronouncements
Basic principles, methods and critical accounting policies
Segment reporting
Scope of consolidation
Notes to the Statements of Income
Notes to the Balance Sheets
Notes to the Statements of Cash Flows
Other information
Statement by the Board of Management
Responsibility Statement
Auditor’s Report
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Press
Jobs and Career
Culture
General Conditions of Use
Privacy Statement
Imprint
Technical Details
Financial Statements
Notes to the Statements of Income
7. Net sales
8. Selling expenses
9. Research and development expenses
10. Other operating income
11. Other operating expenses
12. Personnel expenses/employees
13. Non-operating result
14. Income taxes
15. Income/losses attributable to minority interest
16. Earnings per share from continuing and discontinued operations
Print page
Search
Advanced Search
Download Center
Financial Statements
(PDF 876 KB)
Add to Download Center
Services
Order print version
Event Reminder
Press Newsletter
Would you like to be kept informed about new financial reports from Bayer?
SMS Service
Calendar
Spring Financial News Conference 2008
Investor Conference Call
Info
Notes on our information package and all services
Contact us
RSS
Search
Sitemap
Deutsch